LEADER 01089nam2-2200361---450 
001 990006106100203316
005 20190204130047.0
010   $a978-3-319-20824-4
035   $a000610610
035   $aUSA01000610610
035   $a(ALEPH)000610610USA01
035   $a000610610
100   $a20110331d2015----km-y0itay50------ba
101   $aeng
102   $aDE
105   $aa---||||001yy
200 1 $aEndocannabinoids$fRoger G.
210   $aCham [etc.]$aHeidelberg$cSpringer$dcopyr. 2015
215   $aXII, 475 p.$cill.$d24 cm
225 2 $aHandbook of experimental pharmacology$v231
410  0$1001000320432$12001$aHandbook of experimental pharmacology$v, 231
606 0 $aCanapa indiana$xUso terapeutico$2BNCF
676   $a615.7827
702  1$aPERTWEE,$bRoger G.
801  0$aIT$bsalbc$gISBD
912   $a990006106100203316
951   $a615.782 END 1$b5906 Farm.$c615$d00331109
959   $aBK
969   $aFAR
979   $aPAOLA$b90$c20151215$lUSA01$h1228
979   $aPAOLA$b90$c20151215$lUSA01$h1234
996   $aEndocannabinoids$91383799
997   $aUNISA

LEADER 01362oam  2200409   450 
001 9910707453003321
005 20160822093439.0
035   $a(CKB)5470000002464998
035   $a(OCoLC)957123079
035   $a(OCoLC)995470000002464998
035   $a(EXLCZ)995470000002464998
100   $a20160822d2000      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aBlood glucose test strips $emarketing to Medicare beneficiaries
210  1$a[Washington, D.C.] :$cDepartment of Health and Human Services, Office of Inspector General,$d2000.
215   $a1 online resource (22 pages) $cillustrations
300   $aTitle from title screen (viewed Aug. 19, 2016).
300   $a"June 2000."
300   $a"OEI-03-98-00231."
517   $aBlood glucose test strips 
606   $aMedicare$xClaims administration
606   $aMedicare fraud
606   $aBlood glucose monitoring$zUnited States$xEquipment and supplies$xMarketing
615  0$aMedicare$xClaims administration.
615  0$aMedicare fraud.
615  0$aBlood glucose monitoring$xEquipment and supplies$xMarketing.
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910707453003321
996   $aBlood glucose test strips$93546783
997   $aUNINA